Clinical Trials Browser

Phase 1 × Adenocarcinoma of Lung × Other solid neoplasm × Clear all

Adenocarcinoma of Lung, Mesothelioma, Malignant, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03054298 2025-04-29

CAR T Cells in Mesothelin Expressing Cancers

Phase 1 Completed

65 enrolled 14 charts

GynecologicOther solid neoplasmThoracic

Adenocarcinoma of Lung, Mesothelioma, Malignant, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

Phase 1 Unknown

30 enrolled

BreastGynecologicOther solid neoplasmThoracic

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT02485119 2018-06-04

Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies

Phase 1 Completed

12 enrolled

BreastOther solid neoplasmThoracic

Adenocarcinoma of Lung, Mesothelioma, Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

CAR T Cells in Mesothelin Expressing Cancers

AMT-151 in Patients With Selected Advanced Solid Tumours

Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies